Please login to the form below

Not currently logged in
Email:
Password:

Health Economics

This page shows the latest Health Economics news and features for those working in and with pharma, biotech and healthcare.

Unsure on efficacy, NICE passes J&J’s Darzalex to CDF

Unsure on efficacy, NICE passes J&J’s Darzalex to CDF

measure. The UK’s health technology assessment agency rejected Darzalex (daratumumab) as a third-line treatment for patients with multiple myeloma last March, to the consternation of the company and patients ... The financial terms of the agreement are

Latest news

  • Nobody knew healthcare was so complicated Nobody knew healthcare was so complicated

    Firstly, the concept of ‘short run’and ‘long run’are important from a health economics point of view. ... Think about these variables. And now think about the permutations and combinations of their interaction with health outcomes.

  • Janssen's Imbruvica fails to win NICE backing in lymphoma Janssen's Imbruvica fails to win NICE backing in lymphoma

    Jennifer Lee, director of health economics, market access and reimbursement and advocacy, Janssen UK, said: “This is particularly discouraging news for patients with MCL in the UK as the medicine is

  • Healthcare in the digital age Healthcare in the digital age

    their own health because they want to be in the driver’s seat more than they are now.”. ... It’s one that saw him assume overall leadership for clinical innovation, clinical strategy, medical affairs and Philip’s health economics activities.

  • Being indifferent matters Being indifferent matters

    In health economics, we have what we call ‘indifference curves’ (pictured right) and we define this phenomenon as those curves on a graph (the axes of which represent quantities of two ... is managing director of Catalytic Health, a healthcare

  • Behaviour change needs a quantified approach Behaviour change needs a quantified approach

    When it comes to health, our inability to understand these quirks has been causing serious consequences that need to be addressed. ... Putting behaviour change into action. The pharmaceutical sector has taken great strides in adopting health psychology

More from news
Approximately 1 fully matching, plus 112 partially matching documents found.

Latest Intelligence

  • The rise of real-world evidence The rise of real-world evidence

    However, there are signs this is changing. “EMRs are becoming increasingly attractive options, ”Jason Shafrin, senior research economist at Precision Health Economics, told PME. ... Once a therapy wins approval, companies turn to RWE to understand

  • Digital

    Healthcare terms - Digital.

  • Healthcare systems

    Healthcare terms - Healthcare systems.

  • Drug pricing

    Healthcare terms - Drug pricing.

  • Medical education

    Healthcare terms - Medical education.

More from intelligence
Approximately 0 fully matching, plus 28 partially matching documents found.

Latest appointments

  • Vintura appoints Lieven Annemans as an associate partner Vintura appoints Lieven Annemans as an associate partner

    Healthcare and life sciences consultancy firm Vintura has appointed health-economics professor Lieven Annemans as an associate partner after previously working with him in health-economic areas. ... Bas Amesz, partner at Vintura, said: “Lieven adds

  • VCLS appoints Carole Jones to senior market access role VCLS appoints Carole Jones to senior market access role

    s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support. ... The combination of world class regulatory and health economics expertise allows us to

  • Astellas appoints new senior VP Astellas appoints new senior VP

    Dodson has previously led the alignment of medical affairs practices, policies and standards at Astellas, and she has taken on projects such as expanding the Health Economics and Outcomes Research function,

  • McCann Health expands consulting team McCann Health expands consulting team

    Previously serving Healthcare Management Solutions as its senior director and project leader for health economics, global reimbursement and healthcare policy, Goodman’s expertise lies in public healthcare, economics and healthcare policy.

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    Takeda UK &Ireland has appointed Peter Wheatley Price as market access director, succeeding Ross Selby who moves to head the firm's new US-based global pricing, market access and health ... Prior to this, Wheatley Price was associate director of health

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics